CloudSEK Becomes First Indian-Origin Cybersecurity Company to Receive Investment from a U.S. State Fund

CloudSEK, a Predictive Cyber Threat Intelligence firm specializing in AI-powered attack detection, today announced it has secured a strategic investment from Connecticut Innovations (CI), the strategic venture capital arm of the State of Connecticut, as part of its $10 million Series B2 round. With this investment, CloudSEK becomes the first Indian-origin cybersecurity company to receive […]

MPL Brands NV, Inc. d/b/a Patco Brands, Parent Company of Big Sipz, Secures Key Wins Against BuzzBallz Patents at USPTO

MPL Brands NV, Inc. d/b/a Patco Brands, parent company of Big Sipz, is pleased to announce that it secured Final Written Decisions finding all 26 claims of BuzzBallz’s U.S. Patent Nos. 11,738,904 and 11,932,441 invalid in an inter partes review and a post-grant review at the U.S. Patent and Trademark Office’s Patent Trial and Appeal

Origis Energy and Meta Partner on Landmark Texas Project

Greyhound A Solar project is part of Origis Energy’s fully subscribed ~1 GW energy infrastructure complex in West Texas. Origis Energy, one of America’s leading renewable energy and decarbonization platforms, and Meta have signed a long-term power purchase agreement for the Greyhound A Solar project in West Odessa, Texas. At 303 MWdc (240 MWac), the

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bgin Blockchain Limited – BGIN

Pomerantz LLP is investigating claims on behalf of investors of Bgin Blockchain Limited (“Bgin” or the “Company”) (NASDAQ: BGIN).??Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com?or 646-581-9980, ext.?7980. The investigation concerns whether Bgin and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.? [Click here for

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. – RARE

Pomerantz LLP is investigating claims on behalf of investors of Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the “Company”) (NASDAQ: RARE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Ultragenyx and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of New Era Energy & Digital, Inc. – NUAI

Pomerantz LLP is investigating claims on behalf of investors of New Era Energy & Digital, Inc. (“New Era” or the “Company”) (NASDAQ: NUAI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether New Era and certain of its officers and/or directors have engaged in securities fraud

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas BioPharma, Inc. – ZBIO

Pomerantz LLP is investigating claims on behalf of investors of Zenas BioPharma, Inc. (“Zenas” or the “Company”) (NASDAQ: ZBIO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Zenas and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Graphic Packaging Holding Company – GPK

Pomerantz LLP is investigating claims on behalf of investors of Graphic Packaging Holding Company (“Graphic Packaging” or the “Company”) (NYSE: GPK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Graphic Packaging and certain of its officers and/or directors have engaged in securities fraud or other

CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM

Pomerantz LLP announces that a class action lawsuit has been filed on behalf of shareholders of Quantum Biopharma Ltd. (“Quantum” or the “Company”) (NASDAQ: QNTM).?Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number,

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Charming Medical Ltd. of Class Action Lawsuit and Upcoming Deadlines – MCTA

Pomerantz LLP announces that a class action lawsuit has been filed against Charming Medical Ltd. (“Charming” or the “Company”) (NASDAQ: MCTA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number

Scroll to Top